Also, CSF-1/CSF-1R inhibitors, including kinase inhibitors and antibodies, can attenuate angiogenesis, metastasis, and proliferation of tumor cells and reprogram cancer cell growth in breast cancer models [77, 151]. This evidence concerns the gene CSF1 and neoplasm.